Very true but that's not what drives MRNA. It's the amount of futiure vaccinations that they will sell. That outlook is decreasing as omnicron is not as potent. It's similar to a company having great earnings but their outlook is not quite as good. That factor can hammer a stock which I think is happening here.$Moderna, Inc.(MRNA)$